The Spanish pharmaceutical company said it considered Brookfield’s offer of 10.50 euros a share undervalued the company and ...

Shares of Grifols GRFS lost over 7% on Wednesday after the company announced that Canada-based Brookfield Asset Management has withdrawn its plan to acquire it. Both parties likely failed to arrive at ...

Expect thin trading on U.S. Thanksgiving holiday: The Toronto Stock Exchange will be front and centre today, as the ...

Among French lenders, Societe Generale and BNP Paribas fell around 2% each. The risk premium investors demand to hold French debt rose to its highest level since 2012, a sign of investor angst over ...

The board of Spanish plasma-based medicines producer Grifols has announced the termination of discussions with Brookfield ...

The embattled Spanish drugmaker Grifols SA is in talks with banks to refinance bonds due next year and extend a revolving ...

Fortress is offering 310p per share, valuing the total equity of the company at around £338 million ($428 million; €406 ...

For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...

The Canadian fund Brookfield has decided to withdraw its interest in a public exclusion offer to acquire Grifols due to ...

Barcelona-based Grifols has seen its stock value plummet since January when short seller Gotham City Research accused the company of manipulating debt and earnings reporting by consolidating profit ...

The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...